Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maho, Katsuyama"'
Autor:
Taiki Matsubayashi, Kotaro Yoshioka, Su Su Lei Mon, Maho Katsuyama, Chunyan Jia, Takao Yamaguchi, Rintaro Iwata Hara, Tetsuya Nagata, Osamu Nakagawa, Satoshi Obika, Takanori Yokota
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 2, Pp 102161- (2024)
An increasing number of antisense oligonucleotides (ASOs) have been approved for clinical use. However, improvements of both efficacy and safety in the central nervous system (CNS) are crucial for the treatment with CNS diseases. We aimed to overcome
Externí odkaz:
https://doaj.org/article/a378cd3454e343f1a151222246ffb2f0
Autor:
Chunyan Jia, Su Su Lei Mon, Ying Yang, Maho Katsuyama, Kie Yoshida-Tanaka, Tetsuya Nagata, Kotaro Yoshioka, Takanori Yokota
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 31, Iss , Pp 182-196 (2023)
Antisense oligonucleotides (ASOs) are promising therapeutics for intractable central nervous system (CNS) diseases. For this clinical application, neurotoxicity is one of the critical limitations. Therefore, an evaluation of this neurotoxicity from a
Externí odkaz:
https://doaj.org/article/5fd83a8809054f899afbaeebed69e590
Autor:
Masashi Nagata, Kenichi Negishi, Ayano Mori, Satoshi Nakamatsu, Namiki Sakamoto, Takao Aoyama, Yasunari Mano, Yohei Kawano, Maho Katsuyama, Shuji Shimada, Maki Obana
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:238-244
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant. MTZ is reportedly associated with an increased risk of bleeding. However, the underlying mechanism remains unclear. In this study, we investigated the antiplatelet effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad7728fbec3f0b1d03ac8c47034e7ef0
https://doi.org/10.1248/bpb.b20-00698
https://doi.org/10.1248/bpb.b20-00698
Autor:
Yohei, Kawano, Maki, Obana, Masashi, Nagata, Yasunari, Mano, Maho, Katsuyama, Yuichiro, Yamamoto, Ayako, Maeda-Minami, Kenichi, Negishi, Masamichi, Takagi, Shuji, Shimada, Takao, Aoyama
Publikováno v:
European journal of pharmacology. 917
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant that has been associated with an increased risk of bleeding. However, there is insufficient evidence confirming this association. We hypothesised that 5-HT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a8c12b98914f774cf2515dd6cd853fc
https://pubmed.ncbi.nlm.nih.gov/34818517
https://pubmed.ncbi.nlm.nih.gov/34818517
Autor:
Yohei, Kawano, Maho, Katsuyama, Masashi, Nagata, Maki, Obana, Satoshi, Nakamatsu, Ayano, Mori, Namiki, Sakamoto, Yasunari, Mano, Kenichi, Negishi, Shuji, Shimada, Takao, Aoyama
Publikováno v:
Biologicalpharmaceutical bulletin. 44(2)
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant. MTZ is reportedly associated with an increased risk of bleeding. However, the underlying mechanism remains unclear. In this study, we investigated the antiplatelet effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a6014cb54fc9b8873e7f721ea04c312
https://pubmed.ncbi.nlm.nih.gov/33518675
https://pubmed.ncbi.nlm.nih.gov/33518675
Autor:
Masamichi Takagi, Yuichiro Yamamoto, Kenichi Negishi, Takao Aoyama, Shuji Shimada, Yasunari Mano, Maki Obana, Ayako Maeda-Minami, Maho Katsuyama, Masashi Nagata, Yohei Kawano
Publikováno v:
European Journal of Pharmacology. 917:174640
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant that has been associated with an increased risk of bleeding. However, there is insufficient evidence confirming this association. We hypothesised that 5-HT2A and α2 recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc2e0406e0bade9b210f42220580e8da
https://doi.org/10.1016/j.ejphar.2021.174640
https://doi.org/10.1016/j.ejphar.2021.174640